M Gilliom

Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.

Daniele Longo, Vincent T. DeVita, P L Duffey et al. · Journal of Clinical Oncology · 1991 · 219 citations

Medicine, Oncology, Pharmacology +14

Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy.

Dan L. Longo, Eli Glatstein, P L Duffey et al. · Journal of Clinical Oncology · 1989 · 122 citations

Medicine, Hematology, Oncology +17

Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study

Reuben Ramphal, D J Oblon, Robert J. Sherertz et al. · Antimicrobial Agents and Chemotherapy · 1992 · 87 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Chimeric fusion protein toxin DAB486IL-2 in advanced mycosis fungoides and the Sezary syndrome: correlation of activity and interleukin-2 receptor expression in a phase II study

FM Foss, TA Borkowski, M Gilliom et al. · Blood · 1994 · 82 citations · Full text

Medicine, Immunology, Oncology +10

Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates.

Gerald Batist, D N Carney, Kenneth H. Cowan et al. · Journal of Clinical Oncology · 1986 · 37 citations

Medicine, Oncology, Pharmacology +13